Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111689883B reveals a novel copper-catalyzed route for diaryl sulfones. This method offers mild conditions, air oxidation, and significant cost reduction potential.
Novel CaC2/TEA method improves yield to 78%. Green, mild conditions for API intermediates. Cost-effective supply chain solution for pharmaceutical manufacturing.
Discover advanced synthesis of axial chiral imidazolium salts via patent CN102491947A. Enhanced stability and selectivity for asymmetric catalysis in pharmaceutical manufacturing.
Patent CN113801137A discloses a highly stereoselective organocatalytic route for chiral benzoaromatic heterocyclic dihydropyranones, offering mild conditions and excellent enantiocontrol for pharmaceutical applications.
Novel nickel-copper catalytic method for benzyl esters. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN104388490A reveals high-yield biocatalytic route. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111909048B reveals a green one-pot method for Atorvastatin intermediates. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN1720217A details stable Pd-catalyzed route for lactate precursors. Enhances supply chain reliability and reduces manufacturing complexity for global buyers.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN107266473A reveals high-yield cefotaxime synthesis from 7-ACA. Achieve cost reduction in API manufacturing with scalable, high-purity cephalosporin intermediates.
Novel heteropolyacid-catalyzed route for Vitamin E intermediates offering high yield, environmental safety, and scalable industrial production capabilities for global supply chains.
Patent CN103224484A details a mild bismuth-catalyzed route for statin intermediates, offering significant cost reduction and scalable manufacturing capabilities for global supply chains.
Novel Bronsted acid-catalyzed route for spiro-oxindoles using 2,5-dimethylfuran. High yield, metal-free, scalable pharmaceutical intermediate manufacturing.
Patent CN104557665A reveals novel iridium-catalyzed synthesis for high-purity indole derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN107417570B reveals a high-yield room temperature process for alpha-hydroxy nitriles, offering significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Patent CN116803971A details asymmetric catalytic synthesis for high-purity pharmaceutical intermediates. Discover cost-effective, scalable fluorination solutions for drug development.
Patent CN119462447A reveals a green Cu/MSilicalite-1 catalyzed route for aryl sulfides. Achieve high purity and cost reduction in fine chemical manufacturing.
Patent CN101538202B details a high-yield method for ethyl ferulate using thionyl chloride. Discover cost-effective manufacturing and supply chain advantages for pharma intermediates.
Patent CN103319382B offers a clean synthesis route for Lapatinib intermediates. This method ensures high purity and scalable production for global supply chains.
Novel DDQ-mediated route avoids heavy metals. Ideal for pharma intermediates. Cost-effective, scalable process for reliable supply chain partners.